Leverage & Capital Structure
Leverage Usage: SCD employs moderate leverage to boost its income and returns. As of year-end 2025, the fund had approximately $80 million of borrowings via a margin loan facility (www.stocktitan.net). This equates to roughly 18–20% leverage on total assets – a significant but not extreme level for a hybrid CEF. The leverage is structural (i.e. debt financing) and floating-rate: the weighted average interest borrowing rate was ~5.1% recently (www.stocktitan.net). This means SCD’s interest expense will fluctuate with short-term rates (SOFR/LIBOR). In fact, rising interest costs have pressured net income over the past year; conversely, if interest rates decline, the fund’s financing cost would fall, improving net income margin (seekingalpha.com).
Maturities & Financing Terms: The fund’s leverage is in the form of a margin loan/credit facility rather than long-term bonds, so there is no set maturity date to refinance in the near term (www.stocktitan.net). The loan is typically a demand or short-term facility that can be rolled over but may be subject to collateral requirements. While the lack of a maturity wall is convenient, the variable-rate debt exposes SCD to interest rate risk – as seen by a ~5% interest cost currently, up from prior years. Management’s commentary suggests they expect borrowing costs to ease if/when short-term rates retreat (seekingalpha.com), but there is no guarantee of that.
Capital Raises: In 2025, SCD undertook a 1-for-3 rights offering, issuing 5.7 million new shares (a ~33% increase in share count) and raising approximately $87 million in gross proceeds (www.stocktitan.net). This capital infusion added to the asset base (net assets reached $378 million) and was aimed at improving liquidity and fund size. However, rights offerings dilute NAV if done below NAV – indeed SCD’s offering priced at a slight discount to prevailing NAV (www.sec.gov) (www.sec.gov). This move expanded assets that the manager can invest (and earn fees on), but investors who didn’t participate saw a minor NAV dilution and an immediate widening of the discount. Additionally, SCD has utilized an at-the-market (ATM) share issuance program to gradually sell shares into the market, further incrementally increasing equity capital (www.stocktitan.net). The fund’s capital structure thus consists of common equity (now about 22.9 million shares) and the ~$80 million debt – SCD has no preferred stock or other senior securities reported.
Distribution Coverage (AFFO/FFO Equivalents)
Earnings vs. Distribution: Unlike REITs or operating companies, SCD doesn’t report FFO/AFFO; instead, we examine net investment income (NII) as the proxy for earnings coverage of the dividend. SCD’s NII has consistently covered only a fraction of its dividend. For the fiscal year ended Nov 30, 2025, SCD paid out $1.42 per share in total dividends while generating only $3.9 million total NII across all shares (www.stocktitan.net). On a per-share basis, that’s roughly $0.20 NII/year – meaning only about 14% of the annual distribution was covered by income generated from interest and dividends on the portfolio. On a more current run-rate basis, the fund earned approximately $0.046 per share in monthly NII versus a $0.12 monthly payout, just 39% coverage by income (cefdata.com). The remainder of the distribution has been funded by realized capital gains and other sources.
Sources of Payout: The managed distribution policy allows SCD to include realized gains and return of capital (ROC) in its dividends. Over the past year, the bulk of SCD’s distributions have come from long-term capital gains, not from ordinary income (cefdata.com). In the latest reported quarter, for example, each $0.12 monthly dividend contained only ~$0.006 in net income and ~$0.114 from long-term gains (cefdata.com). Return of capital has not been a major component in the most recent year (0% of the 2024 payout was ROC) but over a three-year period about 21% of distributions were classified as ROC (cefdata.com). The heavy reliance on capital gains means SCD’s ability to sustain the dividend is tied to market performance – it must continually realize enough profits on investments to supplement the shortfall in income. In 2025, SCD realized $46.5 million in gains, which offset large unrealized losses and supported the payout (www.stocktitan.net). If market conditions turn negative (limiting opportunities to take profits), distribution coverage could weaken further, potentially forcing a cut.
Coverage Outlook: The fund’s Undistributed Net Investment Income (UNII) balance is negative (about -$0.98 per share as of mid-2025) (cefdata.com), reflecting that SCD has paid out more in dividends than it has earned in net income in recent periods. This indicates a potential future drag: without an improvement in income or consistently strong realized gains, the fund may eventually need to trim the payout. On the positive side, management expects that lower interest expenses (if rates fall) and deploying the new assets from the rights issue could marginally improve NII going forward (seekingalpha.com). Nonetheless, investors should view SCD’s 9% yield as partly a return of their capital – not purely a yield on underlying earnings – and factor that into their valuation.
Valuation & Comparables
Price vs. NAV: SCD’s market price currently trades at a ~7–8% discount to its net asset value (NAV) (www.franklintempleton.com). In other words, investors can buy SCD shares for about 92–93 cents on the dollar of the fund’s underlying asset value. This is fairly typical for SCD – over the past three years it has averaged a 9% discount to NAV (cefdata.com). The discount has fluctuated in a range (as shallow as ~3.8% premium and as wide as ~-16% in the last few years) depending on market sentiment (cefdata.com). Notably, during 2025 the discount widened substantially as the fund underperformed – SCD’s market price fell -9.2% vs. a -3.6% NAV total return, reflecting the discount moving out by several points (www.stocktitan.net).
Relative to Peers: Within the hybrid balanced CEF category, SCD appears somewhat cheap. Peer funds in the multi-asset income space recently traded, on average, around a -1.5% discount (some near NAV or slight premium) (cefdata.com). SCD’s ~7–8% discount is wider than peers, which could signal a relative value opportunity – or simply price in its weaker earnings coverage. In terms of yield, SCD’s ~9.1% market yield is in line with or slightly above comparable income-focused CEFs, and well above most traditional stock or bond index yields (seekingalpha.com). SCD’s portfolio is roughly 88% in equities (including MLPs) and the rest in fixed-income (www.stocktitan.net) (www.stocktitan.net), giving it a higher equity exposure than many balanced funds – this equity tilt helps drive a high headline yield (via realized gains) but also adds volatility.
P/FFO or Other Metrics: Traditional valuation multiples like P/E don’t directly apply to a fund. If we consider a crude “P/NII” metric (price to net investment income), SCD would look expensive due to its thin income – but this is not very informative given the role of capital gains. A more appropriate lens is the discount to NAV and the sustainability of the distribution. By NAV yield terms, SCD is paying out ~8.5% of NAV yearly (www.franklintempleton.com); that’s a hurdle the portfolio must clear via income + gains. The market’s ~7-8% discount may indicate skepticism about fully earning that yield. Still, if one believes the managers can achieve the blended equity/bond returns needed (and possibly if equity markets are strong), SCD might be undervalued at this discount. Investors may also compare SCD’s performance and risk profile to well-known peers (for example, Gabelli’s GDV or BlackRock’s BCX/GLO funds) to judge if the discount is warranted. At present, SCD’s 1-year Z-statistic is about -1.6 (cefdata.com), meaning its discount is wider than its recent average by more than one standard deviation – a potentially attractive entry point if fundamentals hold steady.
Risks and Red Flags
Underearning the Distribution: The most prominent red flag for SCD is its inadequate dividend coverage. As detailed above, only ~30–40% of the payout comes from recurring income, with the rest coming from portfolio sales. This overdistribution raises the risk of a future dividend cut if market gains don’t persist. The fund’s negative UNII and reliance on non-income sources to fund the dividend highlight this concern (cefdata.com) (www.stocktitan.net). An abrupt downturn in equity markets or MLP values could leave SCD without enough realized gains to maintain the $0.12/month payout. While managed distributions can smooth over short-term fluctuations, they cannot defy economics indefinitely – shareholders could see a reduced dividend in a prolonged weak market. (Notably, the fund’s prospectus warns that distributions are not guaranteed and may be changed or eliminated at any time (www.stocktitan.net).)
Leverage Amplifies Volatility: SCD’s use of ~18% leverage means greater volatility and downside risk. In a rising market, leverage boosts returns; but in a decline, losses are magnified and NAV erosion can accelerate. The fund explicitly faces leverage risk, including the possibility of NAV and price swings being more pronounced than an unlevered portfolio (www.stocktitan.net). If asset values drop significantly, the fund might be forced to deleverage (sell assets to maintain loan ratios), potentially locking in losses. Additionally, the interest expense (currently around 5%) directly reduces net income available for distribution. If short-term rates stay high or rise further, SCD’s NII could shrink, pressuring coverage. The flip side is also true – falling rates would reduce interest cost – but overall, borrowing creates an extra layer of risk that investors must be comfortable with.
Market and Portfolio Risks: As a multi-asset fund, SCD is exposed to equity market risk, credit risk on its bond holdings, and sector-specific risks: - Equity Concentration: The portfolio’s tilt toward information technology and other equities means SCD’s performance can lag a pure bond fund in weak stock markets. In 2025, despite strong S&P 500 returns, SCD’s stock picks underperformed (top equity holdings like Marvell, Apple, Broadcom, Alphabet were a mixed bag) (www.stocktitan.net). Any missteps in stock selection or a tech sector downturn would hurt NAV. On the other hand, about 10–15% of SCD is in energy MLPs and related stocks, which adds commodity sensitivity; these can swing with oil & gas prices, affecting both income and NAV. - Credit & Rate Risk: The fixed-income sleeve (managed by Western Asset) likely includes high-yield corporate bonds or other income securities. Rising interest rates cause unrealized losses in the bond portion (as seen by $51 million in unrealized losses in 2025’s report) (www.stocktitan.net). If rates continue higher, bond values could decline further, and any credit spread widening would hurt the high-yield holdings. Conversely, in a recession scenario, defaults in the credit portfolio could impact NII and NAV. - Foreign Investment Risk: SCD can invest globally (seekingalpha.com). While international exposure provides diversification, it also introduces currency and geopolitical risks. Non-US positions could be affected by foreign market volatility or FX fluctuations, which could either buffer or exacerbate SCD’s performance independent of U.S. markets.
Dilution and Corporate Governance: The 2025 rights offering is a double-edged sword. While it provided fresh capital for the manager to deploy, it also diluted existing shareholders (the new shares were issued at ~90-92.5% of NAV (www.sec.gov)). This kind of dilutive fundraising can be seen as a governance red flag if done repeatedly or without clear benefit to shareholders. Existing investors who did not exercise their rights saw a slight NAV per share drop and enduring wider discount after the offering. The fact that the offering was oversubscribed suggests demand, but it also indicates management’s willingness to increase share count. Additionally, because management fees are calculated on total assets including leveraged assets (www.stocktitan.net), the advisor has an incentive to grow assets (via leverage or new equity) which might not always align with maximizing per-share performance. Investors should keep an eye on fund management’s actions – such as further rights offerings or excessive leverage – that could signal management prioritizing asset growth over shareholder value.
Fee Load: SCD’s expense ratio is on the high side. The baseline management and operating fee is about 1.24% (ex-leverage), and with leverage interest and related costs, the total expense ratio is around 2.4% of net assets (cefdata.com) (www.stocktitan.net). This is not unusual for an actively managed CEF, but it does mean the fund needs to generate that much in annual return before shareholders see any gain. High expenses are a structural hurdle and, combined with leverage costs, partially explain why NII is low. It’s a “silent risk” that erodes returns over time.
Open Questions
- Can SCD Sustain its 9% Distribution? – With only ~40% of the payout covered by income and a negative UNII, will the fund be able to maintain the $0.12 monthly dividend going forward if markets stay volatile? Management has kept the distribution stable so far, but any prolonged shortfall in realized gains could force a cut (www.stocktitan.net). How long can the fund rely on selling winners to fund the dividend? This remains a key uncertainty.
- Will Leverage Help or Hurt in 2026? – The fund’s expanded, levered asset base needs to perform well to justify the 2025 capital raise (www.stocktitan.net). If equity markets and credit markets do well, leverage will magnify the gains and improve coverage. But if 2026 sees a downturn or higher interest rates, leverage could backfire, leading to outsized NAV declines. The direction of interest rates is crucial – a Fed easing cycle could lower SCD’s 5% financing cost and boost NII, but continued tight policy would keep pressure on earnings (seekingalpha.com). Investors are essentially betting that leverage will be accretive, not destructive, in the coming period.
- What’s the Game Plan for New Assets? – SCD’s management raised ~$87 million in new capital via the rights offering. An open question is how effectively those funds have been put to work. Will the added capital simply scale up the existing portfolio (maintaining the status quo), or will it allow new opportunities that can improve returns? Thus far, performance post-offering has lagged benchmarks (www.stocktitan.net). It’s worth asking management (e.g. on conference calls or reports) where they see opportunity and if the larger asset base is benefiting shareholders through better diversification or expense ratios.
- Has SCD’s Underperformance Been Addressed? – The fund badly underperformed its blended benchmark in the last reported year (-3.6% NAV return vs +11.8% for the benchmark) (www.stocktitan.net). Was this due to one-off sector bets (perhaps an overweight in lagging sectors or losing positions) or a structural issue with its strategy? Going forward, will the managers adjust the portfolio mix to better track the benchmark’s risk profile? Consistently missing the benchmark while paying high distributions can lead to NAV erosion. Shareholders should watch if 2025’s lag was an anomaly or indicates the fund’s strategy (high-dividend equities + fixed income) is out of sync with the market environment.
- How Will Macroeconomic Shifts Impact SCD? – SCD sits at the crossroads of equity and credit markets. Questions linger about the macro outlook: If inflation and rates moderate, could SCD’s bond holdings rebound and interest expense fall (a boon to NII)? Conversely, if a recession hits, equities and high-yield bonds could both slump, pressuring SCD’s NAV and its ability to finance distributions. The fund’s concentration in certain sectors (tech, MLPs) adds another layer of macro sensitivity – e.g. how would a tech sector rotation or energy price shock affect the fund? These macro uncertainties mean SCD’s future returns could diverge significantly from recent history.
Conclusion
LMP Capital & Income Fund (SCD) offers a high-octane income play through a leveraged, multi-sector portfolio and a managed 9%+ distribution yield. The fund’s strategy of balancing equities, fixed-income, and MLP assets has delivered strong income and matched its benchmarks in some periods, but recently it struggled and underperformed, raising valid concerns (seekingalpha.com) (www.stocktitan.net). SCD’s dividend policy is generous but heavily dependent on market gains – a defining feature that can either reward investors in bull markets or necessitate painful adjustments in bear phases. The current ~7% discount to NAV provides some margin of safety and upside potential if performance normalizes, yet it likely also reflects the market’s caution about the fund’s coverage shortfall and use of leverage.
For investors, SCD can be an attractive holding for diversified income, but it requires an understanding of its risk profile. One must be comfortable with the idea that part of the “yield” is effectively a slow liquidation (return of capital) unless the managers can consistently earn the distribution via investments. Going forward, watch the fund’s earnings and NAV trends closely. Any changes in the dividend, further capital raises, or shifts in the discount will be telling indicators of how well SCD is navigating its challenges. In summary, SCD unlocks income opportunities but not without challenges – much like the medical battle against sickle cell disease that shares its acronym, it’s a fight for sustainable outcomes. Investors should stay vigilant, sift new data (financial in this case), and weigh if SCD’s high income is worth the accompanying risks in their portfolio.
Sources:
1. Franklin Templeton (Fund Sponsor) – LMP Capital and Income Fund Inc. official data: Pricing, distribution rate, and premium/discount (Feb 2026) (www.franklintempleton.com). 2. CEFData – LMP Capital and Income Fund (SCD) key metrics: portfolio breakdown, leverage, expense ratio, distribution details, and historical discount averages (cefdata.com) (cefdata.com). 3. SEC Filings (Annual Report, Nov 2025) – Fund performance, earnings and distribution coverage, asset size, leverage, and portfolio highlights (www.stocktitan.net) (www.stocktitan.net). 4. StockTitan (SEC filing summary) – Discussion of managed distribution policy and breakdown of NII ($3.9M) vs realized gains in funding $1.42/share annual payout (www.stocktitan.net). Also details on the 2025 rights offering and leverage ($80M at 5.1% rate) (www.stocktitan.net). 5. Seeking Alpha – “SCD Yields 9.27% After a 6% Distribution Bump” (Jan 2026): Independent analysis noting SCD’s global, multi-asset income strategy, use of leverage, and recent underperformance vs benchmark (seekingalpha.com) (seekingalpha.com). 6. NHLBI/NIH Reference – Walk-PHaSST Trial (Sickle Cell Disease), provided for context on the acronym “SCD” (www.ncbi.nlm.nih.gov). (Note: This medical study is unrelated to the fund’s operations, but highlights the origin of the report’s title theme.)
